In Q3, the pharmaceutical industry made significant investments in TV advertising – with many brands unveiling new creative approaches around existing brands, while others introduced new prescription drugs that received FDA approvals. * For “rising” pharma brands – those that didn’t advertise in 2023 or had the largest year-over-year increase in TV